Hypofractionated accelerated CT-guided interstitial ¹⁹²Ir-HDR-Brachytherapy as re-irradiation in inoperable recurrent cervical lymphadenopathy from head and neck cancer.

[1]  A. Nahum,et al.  Severe hypofractionation: Non-homogeneous tumour dose delivery can counteract tumour hypoxia , 2010, Acta oncologica.

[2]  J. Fowler,et al.  Sensitivity analysis of parameters in linear-quadratic radiobiologic modeling. , 2009, International journal of radiation oncology, biology, physics.

[3]  M. Poulsen,et al.  Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  T. Kehwar,et al.  Assessment of tumor control probability for high-dose-rate interstitial brachytherapy implants , 2008 .

[5]  A. Schueler,et al.  Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  A. Garden,et al.  The role of interstitial brachytherapy with salvage surgery for the management of recurrent head and neck cancers , 2007, Cancer.

[7]  J. Shah,et al.  High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers--preliminary results. , 2007, Brachytherapy.

[8]  D. Baltas,et al.  Reirradiation for Recurrent Neck Metastases of Head-and-Neck Tumors Using CT-Guided Interstitial 192Ir HDR Brachytherapy , 2007, Strahlentherapie und Onkologie.

[9]  T. Gupta,et al.  Re-irradiation in the management of isolated neck recurrences: current status and recommendations. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[10]  A. Carvalho,et al.  Salvage for cervical recurrences of head and neck cancer with dissection and interstitial high dose rate brachytherapy , 2006, Radiation oncology.

[11]  K. Harrington,et al.  Manually after-loaded 192Ir low-dose rate brachytherapy after subtotal excision and flap reconstruction of recurrent cervical lymphadenopathy from head and neck cancer. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  P. Frankel,et al.  Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer. , 2005, International journal of radiation oncology, biology, physics.

[13]  E. Vokes,et al.  The expanding role of systemic therapy in head and neck cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  A. Yuen,et al.  Salvage of recurrent head and neck squamous cell carcinoma after primary curative surgery , 2003, Head & neck.

[15]  Bruce Thomadsen,et al.  Inter-society standards for the performance of brachytherapy: a joint report from ABS, ACMP and ACRO. , 2003, Critical reviews in oncology/hematology.

[16]  Young Suk Park,et al.  Measuring response in solid tumors: comparison of RECIST and WHO response criteria. , 2003, Japanese journal of clinical oncology.

[17]  George Fountzilas,et al.  Usefulness of Tumor Volumetry as a Prognostic Factor of Survival in Head and Neck Cancer , 2003, Strahlentherapie und Onkologie.

[18]  R. Sauer,et al.  Pulsed-dose rate brachytherapy with concomitant chemotherapy and interstitial hyperthermia in patients with recurrent head-and-neck cancer. , 2002, Brachytherapy.

[19]  L. Kowalski,et al.  Results of salvage treatment of the neck in patients with oral cancer. , 2002, Archives of otolaryngology--head & neck surgery.

[20]  M. Bollet,et al.  Cervical lymph node relapses of head-and-neck squamous cell carcinoma: is brachytherapy a therapeutic option? , 2001, International journal of radiation oncology, biology, physics.

[21]  R F Labadie,et al.  Nodal volume reduction after concurrent chemo- and radiotherapy: correlation between initial CT and histopathologic findings. , 2000, AJNR. American journal of neuroradiology.

[22]  M. Wannenmacher,et al.  Prognostic impact of total tumor volume and hemoglobin concentration on the outcome of patients with advanced head and neck cancer after concomitant boost radiochemotherapy. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[23]  H D Thames,et al.  Fractionation sensitivities and dose-control relations of head and neck carcinomas: analysis of the randomized hyperfractionation trials. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[24]  J. Bourhis,et al.  Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  H Steininger,et al.  Nodal CT density and total tumor volume as prognostic factors after radiation therapy of stage III/IV head and neck cancer. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[26]  D. Baltas,et al.  A conformal index (COIN) to evaluate implant quality and dose specification in brachytherapy. , 1998, International journal of radiation oncology, biology, physics.

[27]  Nikolaos K. Uzunoglu,et al.  CT-based software for 3-D localization and reconstruction in stepping source brachytherapy , 1997, IEEE Transactions on Information Technology in Biomedicine.

[28]  J. Henk,et al.  Salvage treatment for inoperable neck nodes in head and neck cancer using combined iridium‐192 brachytherapy and surgical reconstruction , 1996, The British journal of surgery.

[29]  H D Thames,et al.  The tumor volume and clonogen number relationship: tumor control predictions based upon tumor volume estimates derived from computed tomography. , 1995, International journal of radiation oncology, biology, physics.

[30]  D. Schreiber,et al.  Interstitial hyperthermia and iridium-192 treatment alone vs. interstitial iridium-192 treatment/hyperthermia and low dose cisplatinum infusion in the treatment of locally advanced head and neck malignancies. , 1995, International journal of radiation oncology, biology, physics.

[31]  L. Licitra,et al.  Salvage surgery of cervical recurrences after neck dissection or radiotherapy , 1993, Head & neck.

[32]  R. Sauer,et al.  [The systematics of acute and chronic radiation sequelae]. , 1993, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[33]  J. Crook,et al.  Brachytherapy of neck metastases. , 1993, The Journal of otolaryngology.

[34]  H. Iro,et al.  Interstitial thermal radiation therapy: five-year experience with head and neck tumors. , 1992, Radiology.

[35]  F. Baillet,et al.  Split course interstitial brachytherapy with a source shift: The results of a new technique for salvage irradiation in recurrent inoperable cervical lymphadenopathy ≥ 4 cm diameter in 23 patients , 1992 .

[36]  P. Levendag,et al.  Reirradiation of recurrent head and neck cancers: external and/or interstitial radiation therapy. , 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[37]  F. Baillet,et al.  Split course interstitial brachytherapy with a source shift: the results of a new iridium implant technique versus single course implants for salvage irradiation of base of tongue cancers in 55 patients. , 1991, International journal of radiation oncology, biology, physics.

[38]  A. Taghian,et al.  Salvage irradiation of oropharynx and mobile tongue about 192 iridium brachytherapy in Centre Alexis Vautrin. , 1988, International journal of radiation oncology, biology, physics.

[39]  D. Dearnaley,et al.  Treatment of ‘inoperable’ neck nodes using surgical clearance and postoperative interstitial irradiation , 1988, The British journal of surgery.

[40]  Ralph W. Gilbert,et al.  Correlation of Tumor Volume with Local Control in Laryngeal Carcinoma Treated by Radiotherapy , 1987, The Annals of otology, rhinology, and laryngology.

[41]  J. Mazeron,et al.  Salvage irradiation of oropharyngeal cancers using iridium 192 wire implants: 5-year results of 70 cases. , 1987, International Journal of Radiation Oncology, Biology, Physics.

[42]  P. Levine,et al.  Intraoperative iodine 125 implants. Their use in large tumors in the neck attached to the carotid artery. , 1983, Archives of otolaryngology.

[43]  J. Fazekas,et al.  Tumor regression and other prognosticators in advanced head and neck cancers: a sequel to the RTOG methotrexate study. , 1983, International journal of radiation oncology, biology, physics.

[44]  L. Anderson,et al.  Permanent iodine‐125 implants in head and neck cancer , 1983, Cancer.

[45]  A. Syed,et al.  Iridium-192 afterloaded implant in the retreatment of head and neck cancers. , 1978, The British journal of radiology.

[46]  A. Syed,et al.  Persistent carcinoma of the oropharynx and oral cavity re‐treated by after‐loading interstitial 192Ir implant , 1977, Cancer.